Precision Therapeutics Inc. Contracts & Agreements

Letter of Intent between Predictive Oncology and Renovaro (Filed With SEC on January 6, 2025)

Form of Series A Warrant (Filed With SEC on July 29, 2024)

Form of Series B Warrant (Filed With SEC on July 29, 2024)

Form of Placement Agent Warrant (Filed With SEC on July 29, 2024)

Form of Warrant Inducement Agreement (Filed With SEC on July 29, 2024)

Sales Agreement, dated as of May 3, 2024, by and between the Registrant and H.C. Wainwright & Co., LLC (Filed With SEC on May 6, 2024)

Separation Agreement and Mutual Release dated effective September 30, 2023, by and between the Company and Bob Myers (Filed With SEC on March 28, 2024)

Employment Agreement dated February 23, 2023 by and between Pamela Bush and Predictive Oncology Inc (Filed With SEC on February 28, 2023)

Employment Offer Letter dated September 30, 2022 by and between Raymond F. Vennare and Predictive Oncology Inc (Filed With SEC on October 20, 2022)

Employment Agreement dated effective November 1, 2022 by and between Raymond F. Vennare and Predictive Oncology Inc (Filed With SEC on October 20, 2022)

Transition and Separation Agreement dated September 15, 2022 by and between J. Melville Engle and Predictive Oncology Inc (Filed With SEC on September 16, 2022)

Amended and Restated Employment Agreement, effective as of August 1, 2022, by and between Julia Kirshner and Predictive Oncology Inc (Filed With SEC on July 26, 2022)

Engagement Letter with H.C. Wainwright & Co., dated May 9, 2022 (Filed With SEC on May 18, 2022)

Form of Investor Warrant (Filed With SEC on May 18, 2022)

Form of Placement Agent Warrant (Filed With SEC on May 18, 2022)

Form of Warrant Amendment Agreement (Filed With SEC on May 18, 2022)

Securities Purchase Agreement (First Offering) (Filed With SEC on May 18, 2022)

Securities Purchase Agreement (Second Offering) (Filed With SEC on May 18, 2022)

Description of Registrants Securities (Filed With SEC on March 31, 2022)

Form of Stock Option Agreement for Employees under Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 31, 2022)

Form of Stock Option Agreement for Executive Officers under Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 31, 2022)

Form of Stock Option Agreement for Directors under Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 31, 2022)

Agreement and Plan of Merger dated November 24, 2021 by and among the Company, Golden Gate Acquisition, Inc., zPredicta, Inc. and Tom Kelly, as Representative (Filed With SEC on December 1, 2021)

Amendment to Engagement Letter (Filed With SEC on June 16, 2021)

Form of Warrant (Filed With SEC on June 16, 2021)

Form of Placement Agent Warrant (Filed With SEC on June 16, 2021)

Form of Securities Purchase Agreement, dated June 14, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on June 16, 2021)

2021 Long Term Incentive Plan (Filed With SEC on May 20, 2021)

Employment Agreement by and between the Company and J. Melville Engle dated effective as of March 19, 2021 (Filed With SEC on April 7, 2021)

Transition and Separation Agreement by and between the Company and Carl Schwartz dated March 19, 2021 (Filed With SEC on March 23, 2021)

Agreement and Release by and between the Company and Carl Schwartz dated March 19, 2021 (Filed With SEC on March 23, 2021)

Offer Letter by and between the Company and J. Melville Engle dated March 19, 2021 (Filed With SEC on March 23, 2021)

Common Stock Purchase Warrant issued to Oasis Capital, LLC dated March 6, 2020 (50) Exhibit 4.30 (Filed With SEC on March 15, 2021)

Form of Warrant (Filed With SEC on February 22, 2021)

Securities Purchase Agreement by and among the Company and the Investors dated February 18, 2021 (Filed With SEC on February 22, 2021)

Registration Rights Agreement by and among the Company and the Investors dated February 18, 2021 (Filed With SEC on February 22, 2021)

Form of Warrant (Filed With SEC on February 12, 2021)

Form of Securities Purchase Agreement, dated February 10, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on February 12, 2021)

Form of Placement Agent Warrant issued to H.C. Wainwright & Co., LLC or its designees in connection with certain financing transactions in 2020 and 2021 (Filed With SEC on January 29, 2021)

Form of Warrant (Filed With SEC on January 26, 2021)

Form of Securities Purchase Agreement, dated January 21, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on January 26, 2021)

Form of Warrant (Filed With SEC on January 21, 2021)

Form of Securities Purchase Agreement, dated January 19, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on January 21, 2021)

Engagement Letter (Filed With SEC on January 12, 2021)

Form of Warrant (Filed With SEC on January 12, 2021)

Form of Securities Purchase Agreement, dated January 8, 2021, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on January 12, 2021)

Form of Warrant dated April 4, 2019 issued in Exchange Offer with Holders of Securities of Helomics Holding Corporation, as amended on September 14, 2020 (Filed With SEC on November 16, 2020)

Amendment #5 to the Amended and Restated Senior Secured Promissory Note originally issued on September 28, 2018 by and among the Company and L2 Capital, LLC (Filed With SEC on September 30, 2020)

Amendment #3 to the Senior Secured Promissory Note originally issued on September 27, 2019 by and among the Company and Oasis Capital, LLC (Filed With SEC on September 30, 2020)

Amendment #2 to the Senior Secured Promissory Note originally issued on February 5, 2020 by and among the Company and Oasis Capital, LLC (Filed With SEC on September 30, 2020)

Form of Amendment to Common Stock Purchase Warrant (Filed With SEC on September 24, 2020)

Amendment #4 to the Amended and Restated Senior Secured Promissory Note originally issued on September 28, 2018 by and among the Company and L2 Capital, LLC (Filed With SEC on July 20, 2020)

Amendment #2 to the Senior Secured Promissory Note originally issued on September 27, 2019 by and among the Company and Oasis Capital, LLC (Filed With SEC on July 20, 2020)

Amendment #1 to the Senior Secured Promissory Note originally issued on February 5, 2020 by and among the Company and Oasis Capital, LLC (Filed With SEC on July 20, 2020)

Asset Purchase Agreement, dated July 1, 2020, by and among the Selling Parties and the Company (Filed With SEC on July 7, 2020)

Form of New Warrant (Filed With SEC on June 26, 2020)

Form of Warrant Exercise Agreement (Filed With SEC on June 26, 2020)

Asset Purchase Agreement, dated May 27, 2020, by and among InventaBioTech, Inc., Soluble Therapeutics, Inc., BioDtech, Inc., and Predictive Oncology Inc (Filed With SEC on June 2, 2020)

Engagement Letter (Filed With SEC on May 8, 2020)

Form of Warrant (Filed With SEC on May 8, 2020)

Securities Purchase Agreement, dated May 6, 2020, by and between Predictive Oncology Inc. and certain Purchasers (Filed With SEC on May 8, 2020)

Promissory Note dated April 20, 2020 between the Company and Park State Bank (Filed With SEC on May 1, 2020)

Exchange Agreement dated April 21, 2020 (Filed With SEC on April 22, 2020)

Description of Registrants Securities (Filed With SEC on April 1, 2020)

Corrected Form of Prefunded Warrant (Filed With SEC on March 23, 2020)

Amendment #3 to the Amended and Restated Senior Secured Promissory Note originally issued on September 28, 2018 by and among the Company and L2 Capital, LLC (Filed With SEC on March 23, 2020)

Amendment #1 to the Senior Secured Promissory Note originally issued on September 27, 2019 by and among the Company and Oasis Capital, LLC (Filed With SEC on March 23, 2020)

Amended and Restated Letter Agreement dated March 15, 2020 by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on March 16, 2020)

Form of Series A Warrant (Filed With SEC on March 16, 2020)

Form of Series B Warrant (Filed With SEC on March 16, 2020)

Form of Prefunded Warrant (Filed With SEC on March 16, 2020)

Securities Purchase Agreement by and among the Company and the Investors dated March 15, 2020 (Filed With SEC on March 16, 2020)

Registration Rights Agreement by and among the Company and the Investors dated March 15, 2020 (Filed With SEC on March 16, 2020)

Form of Common Stock Purchase Warrant issued to Oasis Capital, LLC under Security Purchase Agreement dated February 5, 2020 (Filed With SEC on February 7, 2020)

Securities Purchase Agreement dated February 5, 2020 by and between Predictive Oncology Inc. and Oasis Capital, LLC (Filed With SEC on February 7, 2020)

Senior Secured Promissory Note dated as f February 5, 2020 (Filed With SEC on February 7, 2020)

Security Agreement dated February 5, 2020 by and between Predictive Oncology Inc. and Oasis Capital, LLC (Filed With SEC on February 7, 2020)

Exchange Agreement dated January 31, 2020 (Filed With SEC on February 4, 2020)

Promissory Note to Carl Schwartz dated January 31, 2020 (Filed With SEC on February 4, 2020)

Promissory Note dated November 26, 2019 issued to L2 Capital, LLC (the same form was used for the Promissory Notes dated December 10, 2019 and will be used for a subsequent... (Filed With SEC on December 19, 2019)

Amendment No. 2 dated December 12, 2019 to Amended and Restated Senior Secured Promissory Note issued to L2 Capital, LLC (Filed With SEC on December 17, 2019)

Equity Purchase Agreement by and between the Company and Oasis Capital, LLC dated October 24, 2019 (Filed With SEC on October 25, 2019)

Registration Rights Agreement by and between the Company and Oasis Capital, LLC dated October 24, 2019 (Filed With SEC on October 25, 2019)

Placement Agency Agreement (Filed With SEC on October 10, 2019)

Form of Warrant (Filed With SEC on October 10, 2019)

Common Stock Purchase Warrant issued to Oasis Capital, LLC dated September 27, 2019 (Filed With SEC on September 30, 2019)

Securities Purchase Agreement by and between the Company and Oasis Capital, LLC dated September 27, 2019 (Filed With SEC on September 30, 2019)

Senior Secured Promissory Note issued to Oasis Capital, LLC dated September 27, 2019 (Filed With SEC on September 30, 2019)

Security Agreement by and between the Company and Oasis Capital, LLC dated September 27, 2019 (Filed With SEC on September 30, 2019)

Amendment No. 1 dated September 27, 2019 to Amended and Restated Senior Secured Promissory Note issued to L2 Capital, LLC (Filed With SEC on September 30, 2019)

Form of Amended and Restated Promissory Note payable to Carl Schwartz (Filed With SEC on August 19, 2019)

Form of Amended and Restated Employment Agreement with Carl Schwartz (Filed With SEC on August 19, 2019)

Form of Securities Purchase Agreement (Filed With SEC on July 11, 2019)

Promissory Note issued to Carl Schwartz dated May 30, 2019 (Filed With SEC on June 4, 2019)

Third Amended and Restated Common Stock Purchase Warrant issued to Carl Schwartz dated May 21, 2019 (Filed With SEC on May 23, 2019)

Consulting Agreement dated effective as of May 1, 2019 by and between the Company and Richard Gabriel (Filed With SEC on May 8, 2019)

Placement Agency Agreement (Filed With SEC on April 2, 2019)

Form of Warrant (Filed With SEC on April 2, 2019)

Form of Unit Purchase Option (Filed With SEC on April 2, 2019)

Amendment to Employment Agreement by and between the Issuer and Bob Myers dated August 20, 2018 (Filed With SEC on April 1, 2019)

Amended and Restated 2012 Stock Incentive Plan (Filed With SEC on March 22, 2019)

Placement Agency Agreement (Filed With SEC on March 1, 2019)

Form of Warrant (Filed With SEC on March 1, 2019)

Form of Unit Purchase Option (Filed With SEC on March 1, 2019)

Amended and Restated Common Stock Purchase Warrant issued to Carl Schwartz dated February 6, 2019 (Filed With SEC on February 12, 2019)

Amended and Restated Promissory Note issued to Carl Schwartz dated February 6, 2019 (Filed With SEC on February 12, 2019)

Forbearance Agreement by and between L2 Capital, LLC and the Company dated February 7, 2019 (Filed With SEC on February 12, 2019)

Forbearance Agreement by and between Peak One Opportunity Fund, LP and the Company dated February 7, 2019 (Filed With SEC on February 12, 2019)

Amended and Restated Promissory Note issued to L2 Capital, LLC dated February 7, 2019 (Filed With SEC on February 12, 2019)

Amended and Restated Promissory Note issued to Peak One Opportunity Fund, LP dated February 7, 2019 (Filed With SEC on February 12, 2019)

Amended and Restated Common Stock Purchase Warrant issued to Carl Schwartz dated January 8, 2019 (Filed With SEC on January 14, 2019)

Amended and Restated Promissory Note issued to Carl Schwartz dated January 8, 2019 (Filed With SEC on January 14, 2019)

Subscription Agreement by and between Carl Schwartz and the Company dated January 8, 2019 (Filed With SEC on January 14, 2019)

Common Stock Purchase Warrant issued to Carl Schwartz dated November 30, 2018 (Filed With SEC on December 7, 2018)

Promissory Note issued to Carl Schwartz dated November 30, 2018 (Filed With SEC on December 7, 2018)

Amended and Restated Agreement and Plan of Merger dated October 26, 2018 (Filed With SEC on October 30, 2018)

Common Stock Purchase Warrant issued to L2 Capital, LLC dated September 28, 2018 (Filed With SEC on October 4, 2018)

Common Stock Purchase Warrant issued to Peak One Opportunity Fund, LP dated September 28, 2018 (Filed With SEC on October 4, 2018)

Securities Purchase Agreement by and between the Company and L2 Capital, LLC dated September 28, 2018 (Filed With SEC on October 4, 2018)

Senior Secured Promissory Note issued to L2 Capital, LLC dated September 28, 2018 (Filed With SEC on October 4, 2018)

Registration Rights Agreement by and between the Company and L2 Capital, LLC dated September 28, 2018 (Filed With SEC on October 4, 2018)

Security Agreement by and between the Company and L2 Capital, LLC dated September 28, 2018 (Filed With SEC on October 4, 2018)

Securities Purchase Agreement by and between the Company and Peak One Opportunity Fund, LP dated September 28, 2018 (Filed With SEC on October 4, 2018)

Senior Secured Promissory Note issued to Peak One Opportunity Fund, LP dated September 28, 2018 (Filed With SEC on October 4, 2018)

Registration Rights Agreement by and between the Company and Peak One Opportunity Fund, LP dated September 28, 2018 (Filed With SEC on October 4, 2018)

Security Agreement by and between the Company and Peak One Opportunity Fund, LP dated September 28, 2018 (Filed With SEC on October 4, 2018)

Agreement and Plan of Merger dated June 28, 2018 (Filed With SEC on July 5, 2018)

Consulting Agreement dated effective as of April 1, 2018 by and between the Company and Richard Gabriel (Filed With SEC on April 4, 2018)

Form of Amendment to Warrant (Filed With SEC on February 6, 2018)

Share Exchange Agreement between Skyline Medical Inc. and Helomics Holding Corporation, dated January 11, 2018, including the form of Certificate of Designation of Helomics Series... (Filed With SEC on January 16, 2018)

Underwriting Agreement by and between Skyline Medical Inc. and Dawson James Securities, Inc. dated January 5, 2018 (Filed With SEC on January 10, 2018)

Series E Warrant Agency Agreement by and between Skyline Medical Inc. and Corporate Stock Transfer, Inc. dated January 9, 2018 (Filed With SEC on January 10, 2018)

Form of Series E Warrant Certificate (included as part of Exhibit 4.1) (Filed With SEC on January 10, 2018)

Investor Warrant (Filed With SEC on November 29, 2017)

Securities Purchase Agreement dated November 28, 2017 (Filed With SEC on November 29, 2017)

Registration Rights Agreement dated November 28, 2017 (Filed With SEC on November 29, 2017)

Form of Stock Option Agreement for Executive Officers (Filed With SEC on August 14, 2017)

Form of Stock Option Agreement for Directors (Filed With SEC on August 14, 2017)

AGREEMENT AND PLAN OF MERGER by and among SKYLINE MEDICAL INC. SkylineCyto Acquisition, Inc., CYTOBIOSCIENCE, INC., and ALAN DEAN, AS STOCKHOLDER REPRESENTATIVE Dated as of August... (Filed With SEC on August 11, 2017)

UNDERWRITING AGREEMENT between SKYLINE MEDICAL INC. and DAWSON JAMES SECURITIES, INC., as Representative of the SeveralUnderwriters (Filed With SEC on January 10, 2017)

WARRANT AGENCY AGREEMENT (Filed With SEC on January 10, 2017)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on November 30, 2016)

COMMON STOCK PURCHASE WARRANT SKYLINE MEDICAL, INC. (Filed With SEC on November 30, 2016)

UNIT PURCHASE OPTION FOR THE PURCHASE OF 37,850 UNITS OF SKYLINE MEDICAL, INC. (Filed With SEC on November 30, 2016)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 30, 2016)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on June 17, 2016)

SKYLINE MEDICAL INC. NEW WARRANT AGENCY AGREEMENT (Filed With SEC on March 25, 2016)

EXCHANGE AGENT AGREEMENT (Filed With SEC on March 25, 2016)

SKYLINE MEDICAL INC. NEW WARRANT AGENCY AGREEMENT (Filed With SEC on January 22, 2016)

EXCHANGE AGENT AGREEMENT (Filed With SEC on January 22, 2016)

SKYLINE MEDICAL INC. WARRANT AGENCY AGREEMENT (Filed With SEC on August 20, 2015)

SKYLINE MEDICAL INC. AND CORPORATE STOCK TRANSFER, INC., AS UNIT AGENT FORM OF UNIT AGREEMENT DATED AS OFAUGUST [], 2015 SKYLINE MEDICAL INC. FORM OF UNIT AGREEMENT (Filed With SEC on August 20, 2015)

UNDERWRITING AGREEMENT between SKYLINE MEDICAL INC. and DAWSON JAMES SECURITIES, INC., as Representative of the Several Underwriters SKYLINE MEDICAL INC. UNDERWRITING AGREEMENT (Filed With SEC on August 10, 2015)

SKYLINE MEDICAL INC. WARRANT AGENCY AGREEMENT (Filed With SEC on August 10, 2015)

UNIT PURCHASE OPTION FOR THE PURCHASE OF [l] UNITS OF SKYLINE MEDICAL INC. (Filed With SEC on August 10, 2015)

NUMBER SHARES (Filed With SEC on August 10, 2015)

SKYLINE MEDICAL INC. AND CORPORATE STOCK TRANSFER, INC., AS UNIT AGENT FORM OF UNIT AGREEMENT DATED AS OFAUGUST [], 2015 SKYLINE MEDICAL INC. FORM OF UNIT AGREEMENT (Filed With SEC on August 10, 2015)

SKYLINE MEDICAL INC. FORM OF EXCHANGE AGREEMENT (Filed With SEC on July 24, 2015)

Form of Amendment to Senior Convertible Notes and Agreement by and between Skyline Medical Inc. and Senior Convertible Noteholder Dated as of ____________, 2015... (Filed With SEC on July 24, 2015)

INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on July 20, 2015)

FORMOF Amendment to WAIVER AND CONSENT OF, AND NOTICE TO, HOLDER OF PREFERRED STOCK OF SKYLINE MEDICALINC. (this “Amendment”) Datedas of February ___, 2015 (Filed With SEC on February 2, 2015)

UNDERWRITING AGREEMENT between SKYLINE MEDICAL INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on November 26, 2014)

SKYLINE MEDICAL INC. WARRANT AGENCY AGREEMENT (Filed With SEC on November 26, 2014)

[FORM OF SENIOR CONVERTIBLE NOTE] (Filed With SEC on July 24, 2014)

[FORM OF WARRANT] (Filed With SEC on July 24, 2014)

[FORM OF REGISTRATION RIGHTS AGREEMENT] (Filed With SEC on July 24, 2014)

[FORM OF WAIVER AND CONSENT OF, ANDNOTICE TO, HOLDER OF PREFERRED STOCK OF SKYLINE MEDICALINC. (this “Consent”)] Datedas of July ___, 2014 (Filed With SEC on July 24, 2014)

[FORM OF SECURITIESPURCHASE AGREEMENT] (Filed With SEC on July 24, 2014)

FORM OF WARRANT (Filed With SEC on February 5, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 5, 2014)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on December 19, 2013)

SETTLEMENTAGREEMENT AND MUTUAL GENERAL RELEASE (Filed With SEC on November 14, 2013)

AMENDEDAND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 18, 2013)

BIODRAINMEDICAL, INC. 2012 STOCK INCENTIVE PLAN RESTRICTED STOCK AWARD GRANT (Filed With SEC on June 18, 2013)

FORM OF WARRANT (Filed With SEC on June 12, 2013)

BIODRAINMEDICAL, Inc. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on June 12, 2013)

PROMISSORY NOTE (Filed With SEC on March 14, 2013)

WARRANTTO PURCHASE COMMON STOCK of BioDrainMedical, Inc. (Filed With SEC on February 26, 2013)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on February 26, 2013)

BIODRAIN MEDICAL, INC. 2915 Commers Drive, Suite 900 Eagan, MN 55121 (Filed With SEC on February 8, 2013)

BIODRAIN MEDICAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on February 8, 2013)

EMPLOYMENTAGREEMENT (Filed With SEC on February 8, 2013)

BIODRAIN MEDICAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on February 8, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on February 8, 2013)

BioDrainMedical, Inc. 2915 Commers Drive, Suite 900 Eagan, Minnesota 55121 (Filed With SEC on February 8, 2013)

SETTLEMENTAGREEMENT AND MUTUAL GENERAL RELEASE (Filed With SEC on February 8, 2013)

FIRST AMENDMENT TO LEASE (Filed With SEC on February 8, 2013)

FORM OF WARRANT (Filed With SEC on January 15, 2013)

BIODRAINMEDICAL, Inc. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on January 15, 2013)

BIODRAIN MEDICAL, INC. 2915 Commers Drive, Suite 900 Eagan, MN 55121 (Filed With SEC on November 5, 2012)

BIODRAIN MEDICAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on November 5, 2012)

EMPLOYMENTAGREEMENT (Filed With SEC on November 5, 2012)

BIODRAIN MEDICAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on November 5, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2012)

BioDrainMedical, Inc. 2915 Commers Drive, Suite 900 Eagan, Minnesota 55121 (Filed With SEC on November 5, 2012)

SETTLEMENTAGREEMENT AND MUTUAL GENERAL RELEASE (Filed With SEC on November 5, 2012)

WARRANTTO PURCHASE COMMON STOCK of BioDrainMedical, Inc. (Filed With SEC on June 21, 2012)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on June 21, 2012)

NOTE PURCHASE AGREEMENT (Filed With SEC on April 3, 2012)

AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on April 3, 2012)

NOTE PURCHASE AGREEMENT (Filed With SEC on January 24, 2012)

AMENDMENT NO. 1 TO BIODRAIN MEDICAL, INC. 2008 EQUITY INCENTIVE PLAN (Filed With SEC on June 15, 2011)

AMENDMENTNO. 1 TO BIODRAINMEDICAL, INC. 2008 EQUITY INCENTIVE PLAN (Filed With SEC on June 23, 2010)

CONFIDENTIAL (Filed With SEC on July 1, 2009)

INDEPENDENTCONTRACTOR AGREEMENT (Filed With SEC on April 6, 2009)

CONFIDENTIAL (Filed With SEC on April 6, 2009)

February1, 2009 EMPLOYMENTAGREEMENT (Filed With SEC on April 6, 2009)

BioDrainCapitalization Table Post Merger, Post Financing* $2Million Pre-Money $150KBridge Loan at $750k Pre-Money (Filed With SEC on April 6, 2009)

August11, 2008 EMPLOYMENTAGREEMENT (Filed With SEC on January 12, 2009)

(DATE)September 11, 2008 AMENDMENTTO EMPLOYMENT AGREEMENT (Filed With SEC on January 12, 2009)

BioDrainMedical, Incorporated 2060Centre Pointe Boulevard | Suite 7 | Mendota Heights, Minnesota, USA55120-1269 Phone ###-###-####| fax: +1 ###-###-#### | www.biodrainmedical.com (Filed With SEC on January 12, 2009)

BIODRAINMEDICAL, INC. 699Minnetonka Highlands Lane Orono,Minnesota ###-###-####. (612 ###-###-#### June 9,2008 (Filed With SEC on January 12, 2009)

SECURED CONVERTIBLE NOTEPURCHASE AGREEMENT (Filed With SEC on January 12, 2009)

BIODRAINMEDICAL, INC. SECUREDCONVERTIBLE NOTE DUE APRIL __, 2008 $150,000.00 July __, 2007 (Filed With SEC on January 12, 2009)

SECURITYAGREEMENT (Filed With SEC on January 12, 2009)

Exhibit A NONDISCLOSURE AND NONCOMPETE AGREEMENT (Filed With SEC on November 12, 2008)

BioDrain Medical, Inc. (A Minnesota Corporation) 2008 Equity Incentive Plan October 31, 2008 (Filed With SEC on November 12, 2008)

COMMERCIAL LEASE (Filed With SEC on November 12, 2008)

PRECISION THERAPEUTICS, INC. NOTE PURCHASE AGREEMENT PRECISION THERAPEUTICS, INC. NOTE PURCHASE AGREEMENT (Filed With SEC on November 5, 2007)

NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 5, 2007)

THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on August 24, 2007)

MASTER SECURITY AGREEMENT dated as of December 29, 2006 (Agreement) (Filed With SEC on August 24, 2007)

PROMISSORY NOTE December 29, 2006 (Filed With SEC on August 24, 2007)

WARRANT For Purchase of Shares of Common Stock of PRECISION THERAPEUTICS, INC. (Filed With SEC on August 24, 2007)

SERIES III WARRANT For Purchase of Shares of Common Stock of PRECISION THERAPEUTICS, INC. (Filed With SEC on August 24, 2007)

WARRANT For Purchase of Shares of Common Stock of PRECISION THERAPEUTICS, INC. (Filed With SEC on August 24, 2007)

WARRANT TO PURCHASE 125,000 SHARES OF COMMON STOCK September 25, 2002 (Filed With SEC on August 24, 2007)

WARRANT TO PURCHASE SHARES OF COMMON STOCK, PAR VALUE $.001 PER SHARE, (Filed With SEC on August 24, 2007)

WARRANT TO PURCHASE 26,000 SHARES OF COMMON STOCK (Filed With SEC on August 24, 2007)

WARRANT TO PURCHASE 7,955 SHARES OF COMMON STOCK August 18, 2006 (Filed With SEC on August 24, 2007)

WARRANT TO PURCHASE 181,818 SHARES OF SERIES B CONVERTIBLE PREFERRED STOCK (Filed With SEC on August 24, 2007)

ADVISORY AGREEMENT (Filed With SEC on August 24, 2007)

PRECISION THERAPEUTICS, INC. 2000 STOCK PLAN (Filed With SEC on August 24, 2007)

LEASE (Filed With SEC on August 24, 2007)

Category

Industry

Companies

Contracts

Precision Therapeutics Inc. Contracts & Agreements